|
KCTD20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38829999718482E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99350544352706E-11 |
| Normal-vs-Stage2 |
2.089600E-02 |
| Normal-vs-Stage3 |
5.619900E-03 |
| Normal-vs-Stage4 |
1.055780E-01 |
| Stage1-vs-Stage2 |
1.534240E-01 |
| Stage1-vs-Stage3 |
7.018500E-03 |
| Stage1-vs-Stage4 |
1.461140E-03 |
| Stage2-vs-Stage3 |
6.290800E-01 |
| Stage2-vs-Stage4 |
3.023000E-01 |
| Stage3-vs-Stage4 |
4.538000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.84919998705391E-09 |
| Normal-vs-AfricanAmerican |
4.267000E-01 |
| Normal-vs-Asian |
1.785410E-01 |
| Caucasian-vs-AfricanAmerican |
1.231690E-02 |
| Caucasian-vs-Asian |
8.015800E-01 |
| AfricanAmerican-vs-Asian |
2.325200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44859999995361E-06 |
| Normal-vs-Female |
4.01690000151333E-08 |
| Male-vs-Female |
1.909020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.215900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.48180000492104E-08 |
| Normal-vs-Age(61-80Yrs) |
1.62015999999321E-05 |
| Normal-vs-Age(81-100Yrs) |
5.346000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.350400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.345600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.088200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.633800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.216200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.322100E-03 |
| Normal-vs-Grade 2 |
3.18759463269203E-11 |
| Normal-vs-Grade 3 |
3.591100E-04 |
| Normal-vs-Grade 4 |
2.815000E-01 |
| Grade 1-vs-Grade 2 |
1.386190E-01 |
| Grade 1-vs-Grade 3 |
6.560100E-03 |
| Grade 1-vs-Grade 4 |
1.863020E-03 |
| Grade 2-vs-Grade 3 |
1.715810E-03 |
| Grade 2-vs-Grade 4 |
3.170600E-04 |
| Grade 3-vs-Grade 4 |
1.399600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66422431391311E-12 |
| Normal-vs-ccB subtype |
8.962200E-04 |
| ccA subtype-vs-ccB subtype |
3.815900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.15859999664181E-08 |
| Normal-vs-N1 |
3.400400E-01 |
| N0-vs-N1 |
5.374800E-01 |
|
|
